Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERDAFITINIB Cause Maculopathy? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Maculopathy have been filed in association with ERDAFITINIB (BALVERSA). This represents 0.5% of all adverse event reports for ERDAFITINIB.

5
Reports of Maculopathy with ERDAFITINIB
0.5%
of all ERDAFITINIB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Maculopathy From ERDAFITINIB?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Maculopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ERDAFITINIB Cause?

Death (255) Off label use (86) Diarrhoea (75) Stomatitis (58) Fatigue (45) Onycholysis (44) Disease progression (41) Dry mouth (41) Nail disorder (40) Hyperphosphataemia (39)

What Other Drugs Cause Maculopathy?

PENTOSAN POLYSULFATE (1,389) HYDROXYCHLOROQUINE (227) SERTRALINE (79) METHOTREXATE (69) TOPIRAMATE (47) RANIBIZUMAB (46) TAMOXIFEN (42) SILDENAFIL (37) ADALIMUMAB (36) FINGOLIMOD (34)

Which ERDAFITINIB Alternatives Have Lower Maculopathy Risk?

ERDAFITINIB vs ERENUMAB ERDAFITINIB vs ERENUMAB-AOOE ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE ERDAFITINIB vs ERGOCALCIFEROL ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL

Related Pages

ERDAFITINIB Full Profile All Maculopathy Reports All Drugs Causing Maculopathy ERDAFITINIB Demographics